GMED Globus Medical, Inc. Class A Common Stock

NYSE · Health Care · SEC EDGAR에서 보기 ↗
$88.24
가격 · 8월 19, 2026
기준 재무 정보 8월 6, 2026

Globus Medical, Inc. Class A Common Stock 정보 위키백과 회사 개요

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

더 보기

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Products

Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.

Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.

The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.

Acquisitions

In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.

In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.

In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.

In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.

In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.

In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.

Controversies

In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.

In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.

출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗

Wikidata ↗

GMED 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위

가격
$88.24
시가총액
P/E (TTM)
22.3
EPS (TTM)
$3.92
매출 (TTM)
$2.94B
배당 수익률
ROE
12.1%
부채/자본
52주 범위
$54 – $101

GMED 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의

10년 성과 매출, 순이익, 마진 및 EPS 추세

매출 및 순이익 $2.94B
10-point trend, +421.1%
2016-12-31 2025-12-31
EPS $3.92
10-point trend, +263.0%
2016-12-31 2025-12-31
잉여현금흐름 $589M
9-point trend, +349.5%
2016-12-31 2025-12-31
마진 18.3%
7-point trend, -14.5%
2016-12-31 2023-12-31

가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?

지표
5년 추세
GMED
동종업계 중앙값
P/E (TTM)
5-point trend, -55.6%
22.3
27.5

수익성 총, 영업 및 순이익률; ROE, ROA, ROIC

지표
5년 추세
GMED
동종업계 중앙값
Operating Margin (영업이익률)
5-point trend, +15.7%
16.3%
Net Profit Margin (순이익률)
5-point trend, +41.2%
18.3%
9.8%
ROA
5-point trend, +60.0%
10.2%
5.1%
ROE
5-point trend, +73.3%
12.1%
8.6%
ROIC
5-point trend, +55.2%
9.3%

재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성

지표
5년 추세
GMED
동종업계 중앙값
Current Ratio (유동비율)
5-point trend, -37.3%
4.3
2.7
Quick Ratio (당좌 비율)
5-point trend, +111.4%
2.5

성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR

지표
5년 추세
GMED
동종업계 중앙값
Revenue YoY (매출 YoY)
5-point trend, +206.7%
16.7%
Revenue CAGR 3Y (매출 CAGR 3년)
5-point trend, +206.7%
42.2%
Revenue CAGR 5Y (매출 CAGR 5년)
5-point trend, +206.7%
30.1%
EPS YoY
5-point trend, +172.2%
422.7%
Net Income YoY (순이익 YoY)
5-point trend, +260.5%
422.3%

주당 지표 EPS, 주당 순자산, 주당 현금 흐름, 주당 배당금

지표
5년 추세
GMED
동종업계 중앙값
EPS (Diluted) (EPS (희석))
5-point trend, +172.2%
$3.92

자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율

지표
5년 추세
GMED
동종업계 중앙값

GMED 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력

매수 23 명의 애널리스트
  • 적극 매수 4 17.4%
  • 매수 12 52.2%
  • 보유 7 30.4%
  • 매도 0 0.0%
  • 적극 매도 0 0.0%

12개월 목표 주가

13 명의 애널리스트 · 2026-08-15
중앙값 목표 $100.00 +13.3%
평균 목표 $103.23 +17.0%

실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일

평균 서프라이즈
0.15%
기간 EPS Actual EPS 예상 서프라이즈
2026년 6월 30일 $1.34 $1.12 0.22%
2026년 3월 31일 $1.12 $0.94 0.18%
2025년 12월 31일 $1.28 $1.17 0.11%
2025년 9월 30일 $1.18 $0.80 0.38%
2025년 6월 30일 $0.86 $0.77 0.09%
2025년 3월 31일 $0.68 $0.76 -0.08%

동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업

티커 시가총액 P/E 매출 YoY 순이익률 ROE 매출 총이익률
GMED 22.3 16.7% 18.3% 12.1%
RMD $28.11B 18.7 9.8% 26.9% 23.6% 61.1%
ZBH $28.66B 25.3 7.2% 8.6% 5.6%
BAX $13.05B -10.2 5.7% -8.5% -14.6% 30.0%
PEN $12.20B 68.8 17.5% 12.7% 13.1% 67.1%
GKOS $6.49B -34.4 32.3% -37.0% -26.4% 55.7%
PODD $20.01B 81.7 30.7% 9.1% 16.6% 71.6%
TFX -6.0 17.2% -45.5% -24.6% 56.2%
NVST $3.56B 77.5 8.3% 1.7% 1.5% 54.7%
ITGR $2.69B 27.1 8.0% 5.5% 6.0% 27.0%
ABT $250.18B 33.7 5.7% 14.7% 13.1%

전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름

손익계산서 16
GMED의 연간 손익계산서 데이터
지표 추세 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +519.5% $2.94B $2.52B $1.57B $1.02B $958M $789M $785M $713M $636M $564M $545M $474M
Cost of Revenue 12-point trend, +764.7% $958M $1.04B $548M $264M $239M $217M $180M $159M $150M $135M $132M $111M
Gross Profit 10-point trend, +180.6% · · $1.02B $759M $719M $572M $605M $554M $486M $429M $412M $364M
R&D Expense 12-point trend, +372.5% $147M $164M $124M $73M $97M $85M $60M $55M $44M $45M $36M $31M
SG&A Expense 12-point trend, +524.8% $1.18B $981M $644M $432M $408M $355M $355M $312M $268M $222M $210M $189M
Operating Expenses 10-point trend, +293.9% · · $887M $531M $547M $460M $433M $384M $324M $275M $240M $225M
Operating Income 12-point trend, +246.8% $480M $166M $133M $228M $172M $111M $172M $169M $162M $154M $172M $138M
Other Non-op 12-point trend, +1118.9% $3M $2M $-2M $2M $8M $14M $18M $19M $8M $3M $583.0K $280.0K
Pretax Income 12-point trend, +336.4% $605M $121M $165M $243M $180M $126M $190M $189M $170M $157M $173M $139M
Income Tax 12-point trend, +45.6% $67M $18M $43M $53M $31M $24M $35M $32M $63M $53M $60M $46M
Net Income 12-point trend, +481.6% $538M $103M $123M $190M $149M $102M $155M $156M $107M $104M $113M $92M
EPS (Basic) 12-point trend, +306.1% $3.98 $0.76 $1.09 $1.89 $1.48 $1.04 $1.57 $1.60 $1.12 $1.09 $1.19 $0.98
EPS (Diluted) 12-point trend, +304.1% $3.92 $0.75 $1.07 $1.85 $1.44 $1.01 $1.52 $1.54 $1.10 $1.08 $1.17 $0.97
Shares (Basic) 12-point trend, +43.5% 135,215,000 135,726,000 113,087,000 100,469,000 100,734,000 98,580,000 99,150,000 97,884,000 96,243,000 95,647,000 95,046,000 94,227,000
Shares (Diluted) 12-point trend, +43.6% 137,056,000 137,863,000 114,630,000 102,643,000 103,623,000 100,971,000 101,998,000 101,316,000 97,887,000 96,432,000 96,073,000 95,457,000
EBITDA 11-point trend, +372.6% $757M $420M $278M · $242M $174M $225M $211M $204M $193M $196M $160M
대차대조표 26
GMED의 연간 대차대조표 데이터
지표 추세 202520242023202220212020201920182017201620152014
Cash & Equivalents 8-point trend, +539.6% $526M $784M · · · · $195M $140M $119M $67M $58M $82M
Short-term Investments 11-point trend, -78.8% $31M $106M $50M $296M $250M $187M · $200M $255M $223M $221M $146M
Receivables 12-point trend, +800.1% $679M $558M $503M $213M $164M $142M $154M $137M $117M $92M $78M $75M
Inventory 12-point trend, +734.9% $759M $659M $848M $299M $237M $229M $196M $131M $108M $113M $105M $91M
Prepaid Expense 12-point trend, +1039.4% $65M $50M $45M $21M $18M $18M $17M $15M $11M $15M $7M $6M
Current Assets 12-point trend, +352.2% $2.13B $2.18B $1.92B $983M $865M $822M $687M $631M $620M $514M $545M $470M
PP&E (Net) 12-point trend, +712.5% $564M $562M $587M $244M $221M $217M $200M $172M $143M $124M $115M $69M
PP&E (Gross) 12-point trend, +575.2% $1.27B $1.11B $1.01B $587M $527M $493M $444M $389M $335M $291M $254M $188M
Accum. Depreciation 12-point trend, +494.7% $705M $546M $426M $343M $306M $276M $244M $217M $192M $167M $139M $119M
Goodwill 12-point trend, +2597.6% $1.44B $1.43B $1.43B $197M $180M $157M $129M $124M $124M $106M $92M $53M
Intangibles 12-point trend, +2057.8% $745M $795M $925M $64M $69M $87M $79M $87M $79M $62M $33M $35M
Other Non-current Assets 12-point trend, +7980.1% $79M $75M $79M $37M $36M $32M $22M $10M $8M $928.0K $590.0K $975.0K
Total Assets 12-point trend, +653.7% $5.30B $5.25B $5.09B $2.08B $1.96B $1.68B $1.53B $1.30B $1.08B $928M $834M $704M
Accounts Payable 12-point trend, +521.6% $99M $75M $57M $36M $22M $18M $25M $26M $25M $17M $16M $16M
Accrued Liabilities 12-point trend, +442.4% $334M $261M $240M $92M $91M $78M $63M $60M $53M $46M $54M $61M
Current Liabilities 12-point trend, +457.5% $498M $856M $392M $159M $140M $121M $111M $96M $93M $80M $83M $89M
Capital Leases 7-point trend, +8999.6% $104M $84M $91M $3M $3M $3M $1M · · · · ·
Deferred Tax 11-point trend, +362.4% · $24M $84M $2M $4M $6M $6M $8M $11M $8M $13M $5M
Other Non-current Liabilities 12-point trend, +542.9% $21M $22M $25M $10M $13M $15M $9M $8M $2M $2M $2M $3M
Total Liabilities 12-point trend, +517.7% $730M $1.07B $1.09B $230M $216M $173M $130M $115M $111M $96M $119M $118M
Paid-in Capital 12-point trend, +1708.8% $3.17B $3.03B $2.87B $631M $554M $457M $357M $300M $238M $212M $193M $175M
Retained Earnings 12-point trend, +237.1% $1.39B $1.15B $1.14B $1.24B $1.19B $1.05B $1.05B $893M $736M $629M $525M $412M
AOCI 12-point trend, +1026.1% $15M $-7M $-10M $-25M $-7M $4M $-3M $-7M $-7M $-9M $-2M $-2M
Stockholders' Equity 12-point trend, +681.1% $4.57B $4.18B $4.00B $1.85B $1.74B $1.51B $1.40B $1.19B $968M $832M $715M $585M
Liabilities + Equity 12-point trend, +653.7% $5.30B $5.25B $5.09B $2.08B $1.96B $1.68B $1.53B $1.30B $1.08B $928M $834M $704M
Shares Outstanding 6-point trend, +5.4% · · · · · · 99,825,080 98,573,354 96,657,881 95,929,916 95,319,722 94,705,743
현금 흐름 16
GMED의 연간 현금 흐름 데이터
지표 추세 202520242023202220212020201920182017201620152014
D&A 12-point trend, +1172.6% $277M $253M $146M $68M $70M $63M $53M $42M $42M $39M $24M $22M
Stock-based Comp 12-point trend, +600.0% $50M $54M $53M $33M $31M $27M $26M $22M $15M $11M $10M $7M
Deferred Tax 11-point trend, -3234.3% · $-134M $-58M $-22M $-18M $-4M $4M $971.0K $8M $-4M $6M $-4M
Amort. of Intangibles 12-point trend, +16500.3% $118M $119M $51M $18M $19M $17M $14M $10M $8M $3M $2M $712.0K
Restructuring · $30M · · · · · · · · · ·
Other Non-cash 11-point trend, -191.0% $-111M $243M $-19M · $44M $11M $-66M $-39M $-13M $22M $-31M $-38M
Operating Cash Flow 12-point trend, +851.7% $753M $521M $243M $178M $276M $199M $172M $182M $159M $148M $124M $79M
CapEx 12-point trend, +565.3% $165M $115M $78M $74M $57M $64M $71M $60M $51M $41M $51M $25M
Investing Cash Flow 12-point trend, -255.0% $-355M $-176M $303M $-110M $-376M $-117M $-140M $-193M $-111M $-163M $-153M $-100M
Stock Issued · · · · · · · · · · · $10M
Stock Repurchased 5-point trend, +187.0% $300M $86M $226M $144M · $105M · · · · · ·
Net Stock Activity 5-point trend, -3185.3% $-300M $-86M $-226M · · $-105M · · · · · $10M
Financing Cash Flow 12-point trend, -5346.1% $-679M $-28M $-232M $-110M $54M $-39M $24M $33M $2M $470.0K $4M $13M
Net Change in Cash 12-point trend, -3255.6% $-258M $317M $317M $-43M $-46M $44M $56M $21M $51M $-16M $-25M $-8M
Taxes Paid 8-point trend, +223.8% $99M $159M $101M $78M $45M $25M $34M $31M · · · ·
Free Cash Flow 11-point trend, +981.9% $589M $405M $165M · $219M $135M $101M $122M $108M $131M $71M $54M
수익성 8
GMED의 연간 수익성 데이터
지표 추세 202520242023202220212020201920182017201620152014
Gross Margin 9-point trend, -15.1% · · 65.0% · 75.0% 72.4% 77.1% 77.6% 76.3% 76.1% 75.6% 76.6%
Operating Margin 11-point trend, -44.0% 16.3% 6.6% 8.5% · 17.9% 14.1% 21.9% 23.8% 25.4% 27.3% 31.6% 29.2%
Net Margin 11-point trend, -6.2% 18.3% 4.1% 7.8% · 15.6% 13.0% 19.8% 21.9% 16.9% 18.5% 20.7% 19.5%
Pretax Margin 11-point trend, -29.6% 20.6% 4.8% 10.5% · 18.8% 16.0% 24.2% 26.5% 26.7% 27.9% 31.7% 29.2%
EBITDA Margin 11-point trend, -23.7% 25.8% 16.7% 17.7% · 25.2% 22.1% 28.6% 29.6% 32.1% 34.2% 36.0% 33.8%
ROA 11-point trend, -30.1% 10.2% 2.0% 3.4% · 8.2% 6.4% 11.0% 13.2% 10.7% 11.8% 14.7% 14.6%
ROE 11-point trend, -30.6% 12.1% 2.5% 3.0% · 8.6% 7.0% 11.3% 13.5% 11.9% 13.5% 17.3% 17.5%
ROIC 11-point trend, -40.8% 9.3% 3.4% 2.5% · 8.2% 6.0% 10.0% 11.8% 10.6% 12.3% 15.7% 15.8%
유동성 및 지급능력 2
GMED의 연간 유동성 및 지급능력 데이터
지표 추세 202520242023202220212020201920182017201620152014
Current Ratio 11-point trend, -18.9% 4.3 2.5 4.9 · 6.2 6.8 6.2 6.6 6.7 6.4 6.6 5.3
Quick Ratio 11-point trend, -27.1% 2.5 0.8 1.4 · 3.0 1.2 3.1 5.0 5.3 4.8 4.3 3.4
효율성 3
GMED의 연간 효율성 데이터
지표 추세 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -25.5% 0.6 0.5 0.4 · 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7
Inventory Turnover 11-point trend, -1.8% 1.4 1.4 1.0 · 1.0 1.0 1.1 1.3 1.4 1.2 1.4 1.4
Receivables Turnover 11-point trend, -30.9% 4.8 4.7 4.4 · 6.3 5.3 5.4 5.6 6.1 6.6 7.1 6.9
주당 5
GMED의 연간 주당 데이터
지표 추세 202520242023202220212020201920182017201620152014
Book Value / Share 6-point trend, +127.3% · · · · · · $14.05 $12.03 $10.01 $8.67 $7.50 $6.18
Revenue / Share 11-point trend, +331.5% $21.44 $18.27 $13.68 · $9.25 $7.81 $7.70 $7.04 $6.50 $5.85 $5.67 $4.97
Cash Flow / Share 11-point trend, +562.8% $5.50 $3.78 $2.12 · $2.67 $1.97 $1.69 $1.79 $1.63 $1.78 $1.27 $0.83
Cash / Share 6-point trend, +125.4% · · · · · · $1.96 $1.42 $1.23 $1.38 $0.63 $0.87
EPS (TTM) 12-point trend, +304.1% $3.92 $0.75 $1.07 $1.85 $1.44 $1.01 $1.52 $1.54 $1.10 $1.08 $1.17 $0.97
성장률 9
GMED의 연간 성장률 데이터
지표 추세 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -22.3% 16.7% 60.6% 53.3% 6.8% 21.4% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +63.8% 42.2% 38.0% 25.7% · · · · · · · · ·
Revenue CAGR 5Y 30.1% · · · · · · · · · · ·
EPS YoY 5-point trend, +892.9% 422.7% -29.9% -42.2% 28.5% 42.6% · · · · · · ·
EPS CAGR 3Y 3-point trend, +1366.0% 28.4% -19.5% 1.9% · · · · · · · · ·
EPS CAGR 5Y 31.2% · · · · · · · · · · ·
Net Income YoY 5-point trend, +820.8% 422.3% -16.2% -35.4% 27.5% 45.9% · · · · · · ·
Net Income CAGR 3Y 3-point trend, +557.5% 41.4% -11.6% 6.3% · · · · · · · · ·
Net Income CAGR 5Y 39.4% · · · · · · · · · · ·
가치 평가 (TTM) 9
GMED의 연간 가치 평가 (TTM) 데이터
지표 추세 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +519.5% $2.94B $2.52B $1.57B $1.02B $958M $789M $785M $713M $636M $564M $545M $474M
Net Income TTM 12-point trend, +481.6% $538M $103M $123M $190M $149M $102M $155M $156M $107M $104M $113M $92M
Market Cap 6-point trend, +161.1% · · · · · · $5.88B $4.27B $3.97B $2.38B $2.65B $2.25B
P/E 12-point trend, -9.1% 22.3 110.3 49.8 40.1 50.1 64.6 38.7 28.1 37.4 23.0 23.8 24.5
P/S 6-point trend, +57.7% · · · · · · 7.5 6.0 6.2 4.2 4.9 4.7
P/B 6-point trend, +9.0% · · · · · · 4.2 3.6 4.1 2.9 3.7 3.8
P / Cash Flow 6-point trend, +20.2% · · · · · · 34.2 23.5 24.9 13.8 21.7 28.4
P / FCF 6-point trend, +40.4% · · · · · · 58.1 35.0 36.7 18.2 37.2 41.4
Earnings Yield 12-point trend, +10.0% 4.5% 0.91% 2.0% 2.5% 2.0% 1.6% 2.6% 3.6% 2.7% 4.3% 4.2% 4.1%

재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년

손익계산서
2025-12-312024-12-312023-12-312022-12-312021-12-31
매출 $2.94B$2.52B$1.57B$1.02B$958M
매출 총이익률 % 65.0%75.0%
영업이익률 % 16.3%6.6%8.5%17.9%
순이익 $538M$103M$123M$190M$149M
희석 EPS $3.92$0.75$1.07$1.85$1.44
대차대조표
2025-12-312024-12-312023-12-312022-12-312021-12-31
유동비율 4.32.54.96.2
당좌 비율 2.50.81.43.0
현금 흐름
2025-12-312024-12-312023-12-312022-12-312021-12-31
잉여현금흐름 $589M$405M$165M$219M

트레이딩 시그널 진입 가격 및 위험/보상 비율을 포함한 최근 매수/매도 신호

나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목

📊

중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.

선택 항목이 저장되어 모든 티커에서 유지됩니다.

기관 투자자 (13F) 642개의 제출자 · $5.7B 전체 · 기준일 2026년 6월 30일

분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.

기관 활동 — Q2 2026 대 이전 분기
신규 포지션 청산 포지션 증가함 감소 순주식 변동
82 (-27 이전 분기 대비) 80 (+30 이전 분기 대비) 241 (+22 이전 분기 대비) 176 (-6 이전 분기 대비) +11.4M

Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.

기관 가치 주식 % 추적된 13F 중 유형
VANGUARD CAPITAL MANAGEMENT LLC $403,546,103 5,107,532 7.04% 주식
VANGUARD PORTFOLIO MANAGEMENT LLC $394,606,359 4,994,385 6.89% 주식
STATE STREET CORP $293,540,630 3,714,029 5.12% 주식
Sculptor Capital LP $237,030,000 3,000,000 4.14% 주식
Burgundy Asset Management Ltd. $212,054,428 3,460,983 3.70% 주식
ALLIANCEBERNSTEIN L.P. $205,090,439 2,380,344 3.58% 주식
DIMENSIONAL FUND ADVISORS LP $166,610,599 2,108,728 2.91% 주식
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $135,630,225 1,716,621 2.37% 주식
GEODE CAPITAL MANAGEMENT, LLC $134,690,079 1,704,191 2.35% 주식
Boston Partners $112,054,767 1,418,394 1.96% 주식
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC $101,519,633 1,284,896 1.77% 주식
Quantinno Capital Management LP $96,320,933 1,219,098 1.68% 주식
NORGES BANK $89,048,300 1,127,051 1.55% 주식
FULLER & THALER ASSET MANAGEMENT, INC. $88,055,393 1,114,484 1.54% 주식
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC $88,048,981 1,114,403 1.54% 주식
MANUFACTURERS LIFE INSURANCE COMPANY, THE $84,736,329 1,072,476 1.48% 주식
GENEVA CAPITAL MANAGEMENT LLC $78,941,870 999,138 1.38% 주식
Madison Avenue Partners, LP $73,891,416 935,216 1.29% 주식
Boston Trust Walden Corp $73,637,557 932,003 1.28% 주식
ANTIPODES PARTNERS Ltd $71,581,796 905,984 1.25% 주식
Global Alpha Capital Management Ltd. $67,681,230 856,616 1.18% 주식
Vestal Point Capital, LP $67,158,500 850,000 1.17% 주식
VANGUARD GROUP INC $59,221,500 678,290 1.03% 주식
Stephens Investment Management Group LLC $57,159,864 723,451 1.00% 주식
VANGUARD FIDUCIARY TRUST CO $56,575,822 716,059 0.99% 주식
Clark Capital Management Group, Inc. $54,271,890 686,899 0.95% 주식
AMERICAN CAPITAL MANAGEMENT INC $51,599,219 653,072 0.90% 주식
ANCHOR CAPITAL ADVISORS LLC $51,225,201 648,338 0.89% 주식
Camber Capital Management LP $47,216,000 800,000 0.82% 주식
Capital World Investors $46,664,254 590,612 0.81% 주식
Artemis Investment Management LLP $45,305,914 573,420 0.79% 주식
Swedbank AB $41,113,881 520,363 0.72% 주식
OBERWEIS ASSET MANAGEMENT INC/ $40,461,021 512,100 0.71% 주식
RAYMOND JAMES FINANCIAL INC $39,194,096 496,065 0.68% 주식
Paradice Investment Management LLC $39,023,513 493,906 0.68% 주식
Soleus Capital Management, L.P. $37,049,527 468,922 0.65% 주식
VICTORY CAPITAL MANAGEMENT INC $34,953,155 442,389 0.61% 주식
ENVESTNET ASSET MANAGEMENT INC $34,559,104 437,402 0.60% 주식
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ $33,569,453 424,876 0.59% 주식
FIRST TRUST ADVISORS LP $32,942,568 416,943 0.57% 주식
FMR LLC $32,503,608 411,386 0.57% 주식
Grantham, Mayo, Van Otterloo & Co. LLC $32,370,792 409,705 0.56% 주식
Holocene Advisors, LP $31,598,627 399,932 0.55% 주식
Pembroke Management, LTD $31,513,929 398,860 0.55% 주식
GOLDMAN SACHS GROUP INC $31,286,538 395,982 0.55% 주식
Annex Advisory Services, LLC $30,189,344 350,387 0.53% 주식
Bares Capital Management, Inc. $29,845,058 521,129 0.52% 주식
Capital Impact Advisors, LLC $29,246,895 370,167 0.51% 주식
SIRIOS CAPITAL MANAGEMENT L P $28,050,051 355,019 0.49% 주식
Bridgewater Associates, LP $27,809,466 351,974 0.49% 주식
CONGRESS ASSET MANAGEMENT CO $26,754,761 338,625 0.47% 주식
Terril Brothers, Inc. $25,403,295 321,520 0.44% 주식
Sio Capital Management, LLC $23,846,482 301,816 0.42% 주식
SEGALL BRYANT & HAMILL, LLC $23,729,389 300,334 0.41% 주식
Champlain Investment Partners, LLC $22,982,271 290,878 0.40% 주식
RHUMBLINE ADVISERS $22,513,223 284,942 0.39% 주식
Gotham Asset Management, LLC $22,364,413 283,058 0.39% 주식
UBS Group AG $22,286,430 282,071 0.39% 주식
KENNEDY CAPITAL MANAGEMENT LLC $22,020,640 278,707 0.38% 주식
MetLife Investment Management, LLC $21,771,680 275,556 0.38% 주식
Kathmere Capital Management, LLC $21,450,978 271,497 0.37% 주식
Retirement Systems of Alabama $20,830,354 263,642 0.36% 주식
Foresight Group Ltd Liability Partnership $19,759,724 254,030 0.34% 주식
NICHOLAS COMPANY, INC. $19,699,484 249,329 0.34% 주식
BANK OF AMERICA CORP /DE/ $19,524,872 247,119 0.34% 주식
Varenne Capital Partners $18,807,009 238,200 0.33% 주식
GLENMEDE TRUST CO NA $18,639,881 235,918 0.33% 주식
Mesirow Institutional Investment Management, Inc. $18,549,041 224,266 0.32% 주식
California Public Employees Retirement System $18,120,944 229,350 0.32% 주식
Woodline Partners LP $17,906,826 226,640 0.31% 주식
Swiss National Bank $17,862,344 226,077 0.31% 주식
Corient Private Wealth LP $17,322,828 219,248 0.30% 주식
GABELLI FUNDS LLC $16,671,110 211,000 0.29% 주식
Lightrock Netherlands B.V. $16,367,000 207,151 0.29% 주식
Sofinnova Investments, Inc. $15,802,000 200,000 0.28% 콜 옵션
RENAISSANCE TECHNOLOGIES LLC $15,558,491 196,918 0.27% 주식
STATE OF WISCONSIN INVESTMENT BOARD $15,455,225 195,611 0.27% 주식
LPL Financial LLC $15,233,500 192,805 0.27% 주식
Susquehanna Portfolio Strategies, LLC $15,165,574 191,945 0.26% 주식
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $14,032,018 177,598 0.24% 주식
Leith Wheeler Investment Counsel Ltd. $13,821,540 174,934 0.24% 주식
BlackRock, Inc. $13,638,706 172,620 0.24% 주식
AMERICAN CENTURY COMPANIES INC $13,486,770 170,697 0.24% 주식
WCM INVESTMENT MANAGEMENT, LLC $13,455,918 160,304 0.23% 주식
Leeward Investments, LLC - MA $12,983,476 164,327 0.23% 주식
Walleye Capital LLC $12,358,823 156,421 0.22% 주식
JANUS HENDERSON GROUP PLC $12,232,394 141,973 0.21% 주식
Bellevue Group AG $11,543,993 146,108 0.20% 주식
Sterling Investment Advisors, Ltd. $11,379,257 144,023 0.20% 주식
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $11,223,202 130,260 0.20% 주식
Defilade Capital Management, L.P. $11,032,719 139,637 0.19% 주식
PARADIGM CAPITAL MANAGEMENT INC/NY $10,934,984 138,400 0.19% 주식
Glenmede Investment Management, LP $10,909,935 190,500 0.19% 주식
BNP PARIBAS FINANCIAL MARKETS $10,809,042 136,806 0.19% 주식
ALGERT GLOBAL LLC $10,560,477 133,660 0.18% 주식
GAMCO INVESTORS, INC. ET AL $10,209,435 129,217 0.18% 주식
ArrowMark Colorado Holdings LLC $9,102,268 115,204 0.16% 주식
STRS OHIO $8,815,936 111,580 0.15% 주식
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. $8,503,609 107,627 0.15% 주식
VANGUARD ASSET MANAGEMENT, Ltd $8,430,130 106,697 0.15% 주식

회사 내부자 22 명의 내부자 · 11 임원 · 15 이사

내부자 역할 마지막 활동 보유 주식 수 매수 12개월 매도 12개월 순매수/매도 12개월
Keith W Pfeil President, CEO 2026년 1월 21일 A 0 0 0 $0
Daniel T Scavilla President, CEO 2025년 1월 23일 A 0 0 0 $0
David M Demski President, CEO 2022년 1월 27일 A 0 0 0 $0
Kyle Kline Senior Vice President, CFO 2026년 1월 21일 A 0 0 2 $-2,032,133
Richard A Baron Senior VP and CFO 2014년 5월 2일 M 0 0 0 $0
Anthony L Williams President 2019년 3월 7일 M 0 0 0 $0
Kelly Huller EVP, GC, Corporate Secretary 2026년 2월 25일 M 0 0 3 $-3,441,700
David C Paul Executive Chairman 2026년 1월 21일 A 60,417 0 0 $0
Steven Payne Chief Accounting Officer 2019년 2월 1일 A 0 0 0 $0
Eric Schwartz Senior VP and General Counsel 2018년 6월 25일 M 0 0 0 $0
Brett A Murphy EVP, International Sales 2018년 2월 2일 A 35,217 0 0 $0
David D Davidar 이사 2026년 7월 27일 G 507,675 0 2 $-4,169,000
Ann D Rhoads 이사 2026년 6월 4일 M 40,384 0 3 $-1,402,600
Dan Wolterman 이사 2026년 1월 21일 A 24,025 0 0 $0
Leslie V Norwalk 이사 2026년 1월 21일 A 10,419 0 2 $-557,600
Dan Lemaitre 이사 2026년 1월 21일 A 0 0 0 $0
John A Deford 이사 2026년 1월 21일 A 15,578 0 0 $0
Robert Andrew Douglas 이사 2026년 1월 21일 A 2,005 0 0 $0
Stephen T Zarrilli 이사 2026년 1월 21일 A 0 0 1 $-2,107,250
James R Tobin 이사 2026년 1월 21일 A 0 0 0 $0
Kurt Wheeler 이사 2019년 1월 22일 A 44,319 0 0 $0
Robert Liptak 이사 2019년 1월 22일 A 26,159 0 0 $0

SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당

ETF 보유 현황 99 ETF 보유

가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.

펀드 비중 단위 기준일 출처
FXH · First Trust Exchange-Traded AlphaDE… 2.27% 219,621 NS 2026년 4월 30일 N-PORT
GRPM · Invesco Exchange-Traded Fund Trust 1.93% 118,993 SH 2026년 8월 8일 일간
HTEC · EXCHANGE TRADED CONCEPTS TRUST 1.86% 10,979 NS 2026년 4월 30일 N-PORT
BUL · Pacer Funds Trust 1.53% 21,591 NS 2026년 4월 30일 N-PORT
IHI · iShares Trust 1.30% 536,949 SH 2026년 8월 8일 일간
LFSC · RBB Fund, Inc. 1.27% 16,258 NS 2026년 5월 31일 N-PORT
ROBO · EXCHANGE TRADED CONCEPTS TRUST 1.24% 242,837 NS 2026년 4월 30일 N-PORT
DTEC · ALPS ETF Trust 0.87% 7,891 NS 2026년 5월 31일 N-PORT
TAX · EA Series Trust 0.86% 2,682 NS 2026년 5월 29일 N-PORT
RFG · Invesco Exchange-Traded Fund Trust 0.86% 37,446 SH 2026년 8월 8일 일간
LSEQ · Harbor ETF Trust 0.83% 1,408 NS 2026년 4월 30일 N-PORT
MCOW · Pacer Funds Trust 0.82% 90 NS 2026년 4월 30일 N-PORT
FNY · First Trust Exchange-Traded AlphaDE… 0.55% 31,832 NS 2026년 4월 30일 N-PORT
TMFX · RBB Fund, Inc. 0.54% 2,130 NS 2026년 5월 31일 N-PORT
CZA · Invesco Exchange-Traded Fund Trust 0.51% 11,913 SH 2026년 8월 8일 일간
IJK · iShares Trust 0.49% 662,259 SH 2026년 8월 8일 일간
IVOG · VANGUARD ADMIRAL FUNDS 0.47% 111,810 SH 2026년 8월 8일 일간
MMSC · First Trust Exchange-Traded Fund VI… 0.39% 2,462 NS 2026년 5월 31일 N-PORT
JPME · J.P. Morgan Exchange-Traded Fund Tr… 0.38% 18,545 NS 2026년 4월 30일 N-PORT
GQQQ · EA Series Trust 0.34% 5,950 NS 2026년 5월 29일 N-PORT
BKMC · BNY Mellon ETF Trust 0.31% 21,679 NS 2026년 4월 30일 N-PORT
PTMC · Pacer Funds Trust 0.29% 12,781 NS 2026년 4월 30일 N-PORT
XJH · iShares Trust 0.29% 15,314 SH 2026년 8월 8일 일간
ISCG · iShares Trust 0.29% 35,610 SH 2026년 8월 8일 일간
FNX · First Trust Exchange-Traded AlphaDE… 0.29% 42,239 NS 2026년 4월 30일 N-PORT
SMDX · Tidal Trust III 0.29% 3,969 NS 2026년 4월 30일 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.28% 26,195 NS 2026년 5월 31일 N-PORT
QVMM · Invesco Exchange-Traded Fund Trust … 0.28% 15,001 SH 2026년 8월 8일 일간
ANEW · ProShares Trust 0.26% 244 NS 2026년 5월 31일 N-PORT
IJH · iShares Trust 0.25% 3,909,873 SH 2026년 8월 8일 일간
IVOO · VANGUARD ADMIRAL FUNDS 0.25% 183,180 SH 2026년 8월 8일 일간
VBK · VANGUARD INDEX FUNDS 0.24% 1,499,816 SH 2026년 8월 8일 일간
CLSE · Trust for Professional Managers 0.23% 17,617 NS 2026년 5월 31일 N-PORT
BFOR · ALPS ETF Trust 0.22% 5,809 NS 2026년 5월 31일 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0.21% 56,008 NS 2026년 4월 30일 N-PORT
BBMC · J.P. Morgan Exchange-Traded Fund Tr… 0.21% 46,648 NS 2026년 4월 30일 N-PORT
MIDU · Direxion Shares ETF Trust 0.20% 1,845 NS 2026년 4월 30일 N-PORT
MVV · ProShares Trust 0.20% 3,849 NS 2026년 5월 31일 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0.19% 535,955 NS 2026년 5월 31일 N-PORT
AFSM · First Trust Exchange-Traded Fund VI… 0.17% 2,091 NS 2026년 5월 31일 N-PORT
SCHM · SCHWAB STRATEGIC TRUST 0.17% 300,905 NS 2026년 5월 31일 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0.16% 8,751 NS 2026년 4월 30일 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0.16% 51,771 NS 2026년 4월 30일 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0.16% 7,980 NS 2026년 4월 30일 N-PORT
IYH · iShares Trust 0.15% 67,336 SH 2026년 8월 8일 일간
REVS · Columbia ETF Trust I 0.15% 4,563 NS 2026년 4월 30일 N-PORT
ISCB · iShares Trust 0.14% 5,059 SH 2026년 8월 8일 일간
UMDD · ProShares Trust 0.14% 538 NS 2026년 5월 31일 N-PORT
VHT · VANGUARD WORLD FUND 0.13% 338,547 SH 2026년 8월 8일 일간
DFAS · Dimensional ETF Trust 0.13% 199,853 NS 2026년 4월 30일 N-PORT